DSE : SILCOPHL

Silco Pharmaceuticals Limited — Financial statements

Pharmaceutical Preparations · Bangladesh

Last price 14.8 BDT (At close: Oct 29, 2026) · Market cap 1.54B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Financial statements

Silco Pharmaceuticals Limited (SILCOPHL) reported revenue of 408.71M BDT (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue408.71M431.54M410.10M464.70M559.47M601.06M
Cost of Revenue269.40M278.50M278.25M318.76M372.72M433.30M
Gross Profit139.31M153.04M131.85M145.93M186.75M167.76M
Selling, General & Admin62.34M64.82M62.74M69.74M80.98M80.09M
Other Operating Expenses-2.00-2.00-1.00-1.00-1.00-1.00
Operating Expenses72.31M74.78M72.68M78.75M89.27M88.37M
Operating Income67.00M78.26M59.17M67.18M97.48M79.39M
Interest Expense-482.20K-648.15K-926.65K-195.00K-534.24K-763.79K
Interest & Investment Income38.51K38.51K621.69K401.16K324.84K6.12M
Other Non Operating Income (Expenses)1.54M1.31M1.20M3.30M5.21M4.46M
EBT Excluding Unusual Items68.10M78.96M60.07M70.69M102.48M89.21M
Gain (Loss) on Sale of Investments-929.72K-929.72K-715.45K18.56M6.48M421.74K
Pretax Income67.17M78.03M59.35M89.24M108.96M89.63M
Income Tax Expense32.94M35.38M13.47M20.02M24.51M4.98M
Net Income34.23M42.65M45.88M69.22M84.45M84.65M
Net Income to Common34.23M42.65M45.88M69.22M84.45M84.65M
Shares Outstanding (Basic)103.45M103.81M103.81M103.81M103.81M103.81M
Shares Outstanding (Diluted)103.45M103.81M103.81M103.81M103.81M103.81M
EPS (Basic)0.330.410.440.670.810.82
EPS (Diluted)0.330.410.440.670.810.82
Free Cash Flow17.21M7.54M54.19K-1.47M62.95M-119.22M
Free Cash Flow Per Share0.170.070.00-0.010.61-1.15
Dividend Per Share0.110.100.300.501.00
Gross Margin34.09%35.46%32.15%31.40%33.38%27.91%
Operating Margin16.39%18.14%14.43%14.46%17.42%13.21%
Profit Margin8.37%9.88%11.19%14.90%15.10%14.08%
Free Cash Flow Margin4.21%1.75%0.01%-0.32%11.25%-19.84%
EBITDA156.36M167.29M147.77M153.90M172.16M153.98M
EBITDA Margin38.26%38.77%36.03%33.12%30.77%25.62%
D&A For EBITDA89.35M89.03M88.59M86.72M74.68M74.59M
EBIT67.00M78.26M59.17M67.18M97.48M79.39M
EBIT Margin16.39%18.14%14.43%14.46%17.42%13.21%
Effective Tax Rate49.04%45.35%22.70%22.44%22.49%5.56%
Advertising Expenses3.45M3.55M3.79M4.84M6.20M

Balance sheet

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents28.60M26.26M28.70M30.76M26.72M53.03M
Short-Term Investments1.77M18.97M37.91M19.41M
Cash & Short-Term Investments28.60M26.26M30.47M49.73M64.63M72.44M
Receivables435.57M412.83M419.59M377.51M389.24M390.53M
Inventory465.49M450.67M444.10M444.14M457.84M449.45M
Prepaid Expenses585.00K585.00K210.54K210.54K
Other Current Assets130.23M126.95M160.19M133.55M136.83M139.59M
Total Current Assets1.06B1.02B1.05B1.00B1.05B1.05B
Property, Plant & Equipment1.73B1.74B1.77B1.76B1.67B1.64B
Other Long-Term Assets1.001.00-1.00-1.001.00
Total Assets2.79B2.76B2.82B2.77B2.72B2.70B
Accounts Payable9.42M9.52M9.60M9.75M12.33M16.15M
Accrued Expenses10.73M10.48M9.18M9.27M16.93M21.21M
Current Portion of Leases1.29M4.99M4.26M4.11M3.77M
Current Income Taxes Payable197.61M188.97M285.19M273.70M255.21M240.41M
Other Current Liabilities1.52M2.17M2.56M3.04M2.33M1.42M
Total Current Liabilities220.58M216.13M310.80M295.76M290.91M282.96M
Long-Term Leases5.31M4.11M
Long-Term Deferred Tax Liabilities155.62M154.71M153.71M151.73M150.21M140.50M
Other Long-Term Liabilities-1.001.00-1.001.00
Total Liabilities376.19M370.84M469.82M447.50M441.11M427.57M
Common Stock1.04B1.04B1.04B1.04B1.04B1.04B
Retained Earnings1.38B1.35B1.32B1.29B1.25B1.23B
Comprehensive Income & Other-1.15M-6.92M-10.69M-369.92K
Shareholders' Equity2.42B2.39B2.35B2.32B2.28B2.27B
Total Liabilities & Equity2.79B2.76B2.82B2.77B2.72B2.70B
Total Debt1.29M4.99M9.57M4.11M7.89M
Net Cash (Debt)27.31M21.27M20.90M49.73M60.51M64.56M
Net Cash Per Share0.260.200.200.480.580.62
Filing Date Shares Outstanding103.81M103.81M103.81M103.81M103.81M103.81M
Total Common Shares Outstanding103.81M103.81M103.81M103.81M103.81M103.81M
Working Capital839.32M801.16M744.14M709.17M757.83M769.27M
Book Value Per Share23.2723.0222.6622.3521.9521.85
Tangible Book Value2.42B2.39B2.35B2.32B2.28B2.27B
Tangible Book Value Per Share23.2723.0222.6622.3521.9521.85
Land74.85M74.85M74.85M74.85M74.85M
Buildings1.11B1.08B1.00B880.25M700.05M
Machinery1.61B1.58B1.52B1.44B1.32B
Construction In Progress137.32M128.10M174.96M197.38M394.59M

Cash flow statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income34.23M42.65M45.88M69.22M84.45M84.65M
Depreciation & Amortization93.65M93.65M93.22M90.53M78.49M78.40M
Loss (Gain) From Sale of Investments929.72K929.72K715.45K-18.56M-6.48M-421.74K
Other Operating Activities-56.99M-61.31M7.67M13.22M16.77M-9.20M
Change in Accounts Receivable6.76M6.76M-42.09M11.73M1.30M94.46M
Change in Inventory-6.57M-6.57M46.12K13.70M-8.39M5.26M
Change in Accounts Payable-80.28K-80.28K-145.07K-2.58M-3.82M-2.70M
Change in Other Net Operating Assets1.27M1.27M-20.98M3.22M6.76M6.77M
Operating Cash Flow73.19M77.30M84.31M180.48M169.08M257.21M
Capital Expenditures-55.98M-69.76M-84.26M-181.95M-106.13M-376.43M
Investment in Securities2.92M22.96M22.71M-28.81M136.17M
Other Investing Activities-929.72K-715.45K18.56M6.48M421.74K
Investing Cash Flow-55.98M-67.76M-62.01M-140.68M-128.47M-239.83M
Long-Term Debt Repaid-4.58M-4.30M-4.11M-3.77M-3.54M
Lease Payments-4.86M-4.58M-4.30M-4.11M-3.77M-3.54M
Net Debt Issued (Repaid)-4.86M-4.58M-4.30M-4.11M-3.77M-3.54M
Common Dividends Paid-8.10M-6.75M-19.14M-31.45M-62.62M-62.01M
Other Financing Activities-367.55K-648.26K-926.77K-195.12K-534.53K-763.79K
Financing Cash Flow-13.33M-11.97M-24.37M-35.76M-66.93M-66.31M
Miscellaneous Cash Flow Adjustments3.001.00-1.001.00
Net Cash Flow3.88M-2.44M-2.06M4.05M-26.31M-48.94M
Free Cash Flow17.21M7.54M54.19K-1.47M62.95M-119.22M
Free Cash Flow Margin4.21%1.75%0.01%-0.32%11.25%-19.84%
Free Cash Flow Per Share0.170.070.00-0.010.61-1.15
Levered Free Cash Flow24.95M10.44M-13.12M-11.67M36.24M-142.51M
Unlevered Free Cash Flow25.25M10.84M-12.54M-11.55M36.57M-142.03M
Free Cash Flow After Leases12.36M2.96M-4.25M-5.58M59.18M-122.76M
Cash Interest Paid648.15K648.15K926.65K195.00K534.24K763.79K
Cash Income Tax Paid97.74M97.34M6.73M6.99M8.27M14.95M
Change in Working Capital1.38M1.38M-63.17M26.07M-4.15M103.78M

Ratios

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.54B1.54B1.75B2.53B2.74B2.71B
Enterprise Value1.51B1.52B1.70B2.49B2.64B2.60B
Last Close Price14.8014.6816.6623.7525.1523.90
PE Ratio44.7336.0238.2436.5932.4532.01
PS Ratio3.763.564.285.454.904.51
PB Ratio0.640.640.751.091.201.20
P/TBV Ratio0.640.640.751.091.201.20
P/FCF Ratio89.25203.7032,375.6343.53
P/OCF Ratio20.9919.8820.8114.0316.2110.53
EV/Sales Ratio3.693.524.155.364.724.32
EV/EBITDA Ratio9.379.0711.5216.1915.3516.88
EV/EBIT Ratio22.5219.3928.7837.0927.1132.74
EV/FCF Ratio87.66201.2431,423.9041.99
Debt / Equity Ratio0.000.000.000.000.00
Debt / EBITDA Ratio0.010.030.060.020.05
Debt / FCF Ratio0.070.66176.560.07
Net Debt / Equity Ratio-0.01-0.01-0.01-0.02-0.03-0.03
Net Debt / EBITDA Ratio-0.17-0.13-0.14-0.32-0.35-0.42
Net Debt / FCF Ratio-1.59-2.82-385.7933.88-0.960.54
Asset Turnover0.140.150.150.170.210.23
Inventory Turnover0.580.620.630.710.820.96
Quick Ratio2.102.031.451.451.561.64
Current Ratio4.804.713.393.403.603.72
Return on Equity (ROE)1.43%1.80%1.96%3.01%3.72%3.75%
Return on Assets (ROA)1.48%1.75%1.32%1.53%2.25%1.85%
Return on Invested Capital (ROIC)1.43%1.82%1.99%2.32%3.42%3.58%
Return on Capital Employed (ROCE)2.60%3.10%2.40%2.70%4.00%3.30%
Earnings Yield2.24%2.78%2.61%2.73%3.08%3.12%
FCF Yield1.12%0.49%0.00%-0.06%2.30%-4.40%
Dividend Yield0.74%0.74%0.59%1.23%1.89%3.83%
Payout Ratio23.68%15.82%41.72%45.43%74.15%73.25%
Total Shareholder Return0.43%0.74%0.59%1.23%1.89%3.83%